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Effect of injection tool on incidence of head and neck abscesses at
slaughter
Abstract
Objective: To test the effect of injection device (conventional syringe and needle versus needle-free injection
device [NFID]) on the incidence of head and neck abscesses at slaughter. Materials and methods: Pigs raised
under antibiotic-free (ABF) conditions (n=3424) were vaccinated first with combined Mycoflex and
Circoflex (Boehringer Ingelheim Vetmedica Inc, St Joseph, Missouri) and second with ER Bac Plus (Pfizer
Inc, Pfizer Animal Health, New York, New York), each via either conventional syringe and needle (Needle) or
NFID. The first vaccination was given on the right side of the neck 1 day post weaning and the second on the
left side of the neck 70 days post weaning. Four treatment groups were based on the vaccination injection
methods: Needle-Needle; Needle-NFID; NFID-Needle; and NFID-NFID. Results: At slaughter, 3134
carcasses were evaluated for head and neck abscesses. The incidence of abscesses among the treatment groups
did not differ (P>.05). More abscesses occurred on the right side of the neck (0.45%; P<.05) than on the left
(0.13%). Overall abscess incidence (0.57%) was less than that typically observed in similarly sourced ABF
pigs (2.51%) produced under field conditions and harvested at the same processing facility. Implications:
Under the conditions of this study, incidence of head and neck abscesses at slaughter does not differ by
injection device. Lower abscess incidence in study pigs than in ABF pigs under field conditions may be
attributed to picking up small pigs for vaccination, frequent changing of needles, and not hurrying the
vaccination process.
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Summary
Objective: To test the effect of injection 
device (conventional syringe and needle 
versus needle-free injection device [NFID]) 
on the incidence of head and neck 
abscesses at slaughter.
Materials and methods: Pigs raised under 
antibiotic-free (ABF) conditions (n = 3424) 
were vaccinated first with combined Myco-
flex and Circoflex (Boehringer Ingelheim 
Vetmedica Inc, St Joseph, Missouri) and 
second with ER Bac Plus (Pfizer Inc, Pfizer 
Animal Health, New York, New York), each 
via either conventional syringe and needle 
(Needle) or NFID. The first vaccination was 
given on the right side of the neck 1 day post 
weaning and the second on the left side of the 
neck 70 days post weaning. Four treatment 
groups were based on the vaccination injec-
tion methods: Needle-Needle; Needle-NFID; 
NFID-Needle; and NFID-NFID.
Results: At slaughter, 3134 carcasses were 
evaluated for head and neck abscesses. The 
incidence of abscesses among the treat-
ment groups did not differ (P > .05). More 
abscesses occurred on the right side of the 
neck (0.45%; P < .05) than on the left 
(0.13%). Overall abscess incidence (0.57%) 
was less than that typically observed in simi-
larly sourced ABF pigs (2.51%) produced 
under field conditions and harvested at the 
same processing facility.
Implications: Under the conditions of this 
study, incidence of head and neck abscesses 
at slaughter does not differ by injection 
device. Lower abscess incidence in study 
pigs than in ABF pigs under field condi-
tions may be attributed to picking up small 
pigs for vaccination, frequent changing of 
needles, and not hurrying the vaccination 
process. 
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Resumen - Efectos del dispositivo de 
inyección en la incidencia de abscesos en 
la cabeza y el cuello en el matadero
Objetivo: Probar el efecto del dispositivo 
de inyección (aguja y jeringa convencional 
contra dispositivo de inyección sin aguja 
[NFID por sus siglas en inglés]) en la inci-
dencia de abscesos en la cabeza y el cuello 
en la matanza.
Materiales y métodos: Los cerdos criados 
bajo condiciones libres de antibióticos 
(ABF por sus siglas en inglés) (n = 3424) 
fueron vacunados primero con la com-
binación de Mycoflex y Circoflex (Boeh-
ringer Ingelheim Vetmedica Inc, St Joseph, 
Missouri) y segundo con ER Bac Plus 
(Pfizer Inc, Pfizer Animal Health, New 
York, New York), cada uno vía aguja y jer-
inga convencional (Needle por su nombre 
en inglés) ó NFID. La primera vacunación 
se aplicó en el lado derecho del cuello el 
día1 después del destete y la segunda en el 
lado izquierdo del cuello 70 días después 
del destete. Cuatro grupos de tratamiento 
se basaron en métodos de inyección de 
vacunación: Needle-Needle; Needle-NFID; 
NFID-Needle; y NFID-NFID.
Resultados: En la matanza, se evaluaron 
los abscesos en la cabeza y cuello de 3134 
canales. La incidencia de abscesos entre los 
grupos de tratamiento no difirió (P > .05). 
Se presentaron más abscesos en el lado 
derecho del cuello (0.45%; P < .05) que en 
el izquierdo (0.13%). La incidencia total de 
abscesos (0.57%) fue menor que la obser-
vada típicamente en cerdos ABF (2.51%) 
producidos bajo condiciones de campo y 
cosechados en las mismas instalaciones de 
procesamiento.
Implicaciones: Bajo las condiciones de este 
estudio, la incidencia de abscesos de cabeza 
y cuello en la matanza no difirieron debido 
al dispositivo de inyección. La menor inci-
dencia de abscesos en los cerdos de estudio 
que en los cerdos ABF bajo condiciones de 
campo, puede ser atribuida a que se levan-
tan los cerdos pequeños para la vacunación, 
el cambio frecuente de agujas, y a que no se 
apresura el proceso de vacunación.
 
Résumé - Effet de l’instrument à injec-
tion sur l’incidence d’abcès à la tête et au 
cou au moment de l’abattage
Objectif: Vérifier l’effet de l’instrument 
à injection (seringue conventionnelle et 
aiguille versus un mécanisme d’injection 
sans aiguille [NFID]) sur l’incidence d’abcès 
à la tête et au cou au moment de l’abattage.
Matériels et méthodes: Des porcs élevés 
dans des conditions sans antibiotique 
(ABF) (n = 3424) ont été vaccinés pre-
mièrement avec une combinaison Mycoflex 
et Circoflex (Boehringer Ingelheim Vet-
medica Inc, St-Joseph, Missouri) et deux-
ièmement avec ER Bac Plus (Pfizer Inc, 
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Abscesses found in the neck and head area of pigs result in trimming and condemnation of the entire head 
at slaughter. Since the head is commonly 
viewed as being of little value relative to the 
rest of the carcass, head losses are largely 
ignored. However, in economic terms, 
the head has a value that ranges from 
$2.27 to $4.81, with an average value of 
$3.49 (confidential Agristats data from 11 
processing plants November 2009; all cur-
rency in $US). In 2008, commercial hog 
slaughter totaled 116.5 million head in the 
United States.1 From these values, approxi-
mate cost of head and neck abscesses to 
the swine industry can be estimated. For 
every 1% of head loss or condemnation, 
the American swine industry experiences 
economic loss in excess of 3 million US 
dollars. These abscesses are often found in 
the area where injections or vaccinations 
are commonly given. Typical presentations 
of head and neck abscesses on carcasses at 
slaughter are shown in Figure 1.
Figure 1: Typical presentation of head and neck abscesses on market hog 
carcasses at slaughter. (A) Arrow indicates an externally visible neck lesion 
resulting in head condemnation. (B) Arrows indicate pus drainage from an 
abscess in the neck area.
Needle-free injection devices (NFIDs) 
have been promoted within the swine 
industry in the belief that such devices 
may allow use of lower antigen doses in 
vaccination,2,3 minimize food-safety risk 
by eliminating broken needles in pork,4 
reduce transmission of disease agents, and 
reduce contamination of the injection site, 
compared to typical injection via a conven-
tional needle.
The purpose of this study was to evaluate 
the effect of the injection device (conven-
tional syringe and needle versus NFID) on 
the incidence of head and neck abscesses 
identified at slaughter. The hypothesis tested 
A
B
Pfizer Animal Health, New York, New York) 
chacun via une seringue conventionnelle 
et une aiguille (Aiguille) ou avec NFID. La 
première vaccination a été donnée du côté 
droit du cou 1 jour post-sevrage et la deux-
ième du côté gauche du cou 70 jours post-
sevrage. Quatre groupes de traitement ont 
été constitués selon la méthode d’injection: 
Aiguille-Aiguille; Aiguille-NFID; NFID-
Aiguille; NFID-NFID.
Résultats: Au moment de l’abattage, 3134 
carcasses ont été évaluées pour la présence 
d’abcès à la tête et au cou. L’incidence des 
abcès parmi les groupes de traitement ne 
différait pas (P > .05). Plus d’abcès ont été 
retrouvés sur le côté droit du cou (0.45%; 
P < .05) que sur le côté gauche (0.13%). 
L’incidence globale des abcès (0.57%) était 
moindre que celle observée (2.51%) chez 
des porcs ABF élevés dans des conditions 
de champs et pris à la même usine.
Implications: Dans les conditions de réali-
sation de cette étude, l’incidence d’abcès de 
la tête et du cou au moment de l’abattage ne 
différait pas selon l’appareil à injection util-
isé. Une incidence plus faible d’abcès chez 
les porcs de l’étude comparativement à des 
porcs en condition de champs pourrait être 
attribuable au fait que des porcs plus petits 
ont été pris pour la vaccination, le change-
ment fréquent des aiguilles, et le fait de ne 
pas précipiter le processus de vaccination.
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was that the incidence of head and neck 
abscesses was different for the two devices.
Materials and methods
Pigs in this trial were cared for in accor-
dance with the Cargill Pork LLC Swine 
Welfare Policy. All practices and protocols 
in this study were those followed within 
the Cargill Pork LLC production system.
Pigs in this study were managed under an 
antibiotic-free (ABF) program. Being ABF 
requires that pigs receive no antibiotics 
via injection or by feed or water medica-
tion. Pigs requiring individual treatment 
with injectable antibiotics were tagged and 
excluded from the ABF program and from 
this study. All pigs evaluated at slaughter 
had received no injections other than neo-
natal iron and two injectable vaccinations 
post weaning. Weaned pigs of both genders 
(N = 3424), sourced from 16 sow farms 
managed under the same ABF program, 
were placed in a single wean-to-finish barn. 
Wean age ranged from 17 to 24 days with 
a 19-day average. Pigs treated with anti-
biotics prior to weaning were tagged and 
excluded from this trial.
The wean-to-finish barn was a fully-slatted 
curtain-sided building with mechani-
cal and tunnel ventilation capabilities. 
Approximately 40 pigs were placed in each 
pen, with each pen containing either gilts 
or barrows to allow for split-sex feeding.
At restraint for the first vaccination, 
pigs within each pen were assigned to 
four treatment groups and ear-tagged to 
designate study group by alternating treat-
ments for pigs sequentially caught. The 
four treatment groups were approximately 
equally represented in each pen. Ear tags 
were color-coded to assure that the cor-
rect device was used for each injection, 
therefore it was not possible for the vaccine 
administrator to be blinded to treatment. 
All pigs in the trial were negative for por-
cine reproductive and respiratory syndrome 
(PRRS) virus (sourced from known PRRS-
negative sow farms) and positive for Myco-
plasma hyopneumoniae (sourced from known 
M hyopneumoniae-positive sow farms).
The first injection, given on the right side 
of the neck 1 day after weaning, contained 
a combination of 1 mL of Mycoplasma hyo-
pneumoniae vaccine (Mycoflex; Boehringer 
Ingelheim Vetmedica Inc, St Joseph, Mis-
souri) and 1 mL of porcine circovirus type 
2 vaccine (Circoflex; Boehringer Ingelheim 
Vetmedica Inc), resulting in a 2 mL-total 
dose. A second vaccination, given on the left 
side of the neck approximately 70 days after 
weaning, contained 2 mL of Erysipelothrix 
rhusiopathiae vaccine (ER Bac Plus; Pfizer 
Inc, Pfizer Animal Health New York, New 
York). An AcuShot NFID (AcuShot Needle-
Free Inc, Winnipeg, Manitoba, Canada) was 
used for all NFID vaccinations. Ideal D3 
20-gauge, 1/2-inch needles (Neogen Corpo-
ration, Lexington, Kentucky) were used for 
the first needle vaccination, and Ideal D3 
16-gauge, 1-inch needles (Neogen Corpora-
tion) for the second needle vaccination. 
The four treatment groups, Needle-Needle, 
Needle-NFID, NFID-Needle, and NFID-
NFID, were based on vaccination injection 
methods (Table 1).
Trial investigators administered all vaccina-
tions. For the first vaccination, pigs were 
individually picked up and vaccinated via 
needle or NFID. For the second vaccina-
tion, pigs were crowded in the pen and 
vaccinated via needle or NFID. For both 
first and second vaccinations, needles were 
changed after all pigs in each pen had been 
injected (approximately every 20 pigs).
At slaughter, USDA inspectors identified 
carcasses with head and neck abscesses via 
the inspection process used daily at the 
slaughter facility. A plant worker indicated 
which side of the neck the abscess was on 
prior to removing the condemned head. 
Trial investigators documented the number 
of abscesses and the side of the neck where 
the abscess was located.
Statistical analysis was performed using 
SAS software version 9.2 for Windows 
(SAS Institute Inc, Cary, North Carolina). 
Fisher’s exact test was used to test for 
association between treatment groups. The 
incidence of abscesses was calculated as the 
percentage of carcasses in each group with 
abscesses. McNemar’s test was used to test 
for a difference in percentage of abscesses 
between the left and right sides. For both 
tests, a P value < .05 was considered statis-
tically significant.
Results
Table 1 shows numbers of pigs per treat-
ment group at the beginning of the trial 
and the number of carcasses evaluated at 
the packing plant. Losses (< 10% of begin-
ning inventory) were due to mortality, 
individual treatment with antibiotics, non-
marketable pigs (culls), or loss of identity 
prior to marketing. No outbreaks of clini-
cal illness involving the entire group of pigs 
at the site occurred during the trial.
In total, 3134 pigs from this trial were eval-
uated for head and neck abscesses at a com-
mercial processing facility in Ottumwa, 
Iowa, with 18 abscesses identified (0.57%). 
From June 1, 2009, through September 2, 
2009, 40,866 head of ABF pigs were deliv-
ered from contract producers’ sites to this 
processing plant, with an average incidence 
of head condemnation due to abscesses of 
2.51% (personal communication, Process 
Improvement Department, Cargill Wapello 
County Plant; 2009). Results are presented 
in Table 2. There was no statistically sig-
nificant difference in the abscess incidence 
among the four treatment groups (P > .05; 
Fisher’s exact test). There was, however, a 
statistically significant difference between 
the proportions of abscesses on the right 
side (0.45%) and on the left side of the 
neck (0.13%) (P < .05; McNemar’s test).
Table 1: Percentage of pigs per treatment group vaccinated using two 
injection methods* and evaluated for abscesses at slaughter
Treatment groups
1st  vaccination† Needle Needle NFID NFID
Totals
2nd  vaccination‡ Needle NFID Needle NFID
No. of study pigs 857 855 857 855 3424












*    Vaccines were administered either by conventional needle and syringe (Needle) or 
by needle-free injection device (NFID).
†    Mycoflex and Circoflex vaccines were combined (Boehringer Ingelheim Vetmedica 
Inc, St Joseph, Missouri; total 2 mL) and injected on the right side of the neck 1 day 
post weaning in pigs weaned at a mean of 19 days of age. 
‡    ER Bac Plus (Pfizer Inc, Pfizer Animal Health New York, New York, total, 2 mL) was 
injected on the left side of the neck 70 days post weaning.
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Discussion
Results of this study suggest that the 
incidence of head and neck abscesses was 
not different for the two devices tested 
(conventional needle or NFID). All pigs 
evaluated at slaughter, conforming with 
the ABF program, received neonatal iron 
injections and two vaccination injections 
via the methods identified. It must be 
kept in mind that the study pigs evaluated 
at slaughter received no other injections. 
This allowed determination of the effect 
of injection tool on incidence of head and 
neck abscesses. The incidence of abscesses 
on the right side (Mycoflex-Circoflex 
injection) was significantly greater than 
the incidence on the left side (ER Bac Plus 
injection). Identifying a root cause for this 
difference is speculation. Possible factors 
influencing the difference in abscess inci-
dence on the right versus left side include 
needle size, age of pig, inherent difference 
in vaccines administered, and previous 
neonatal iron injection. For the groups 
injected with a needle and syringe, a 20-
gauge needle was used for the injection on 
the right and a 16-gauge needle was used 
on the left. The pigs were younger when 
the vaccine was given on the right, and it 
was administered with each pig being held 
and restrained for either the conventional 
needle or NFID method. For the second 
vaccination, pigs were older and crowded 
in the pen when vaccinated via needle or 
NFID method. Finally, because most people 
are right-handed, it is likely that most pigs 
received a neonatal iron injection on the 
right side; however these data were not 
required or documented for this study. Prior 
tissue damage or lingering residue from 
the iron injection could contribute to an 
increased likelihood of abscess development. 
The overall incidence of abscesses for pigs in 
all treatment groups was 0.57%, which was 
less than the percentage commonly seen in 
ABF pigs processed in this packing facility 
(2.51% for the 3-month period from June 
2009 to September 2009). Vaccination tech-
niques, including picking up the younger 
pigs for injection, frequent changing of 
needles, and not hurrying the vaccination 
process, were all optimized in this trial.
Implications
• Under the conditions of this study, the 
incidence of head and neck abscesses 
at slaughter does not differ whether a 
conventional needle or NFID is used.
• The lower overall incidence of 
abscesses in this study, compared to 
that in non-study pigs raised under 
similar field conditions, may be attrib-
uted to picking up the younger pigs 
for injection, frequent changing of 
needles, and not hurrying the vaccina-
tion process.
References
1. National Agricultural Statistics Service, Agricul-
tural Statistics Board, United States Department 
of Agriculture. Livestock Slaughter 2008 Sum-
mary. March 2009. Available at: http://usda.
mannlib.cornell.edu/usda/nass/LiveSlauSu/
/2000s/2009/LiveSlauSu-03-06-2009.txt. 
Accessed 13 August 2010.
2. Mitragotri S. Current status and future pros-
pects of needle-free liquid jet injectors. Nat Rev 
Drug Discov. 2006;5:543–548.
3. Mitragotri S. Immunization with needles. Nat 
Rev Immunol. 2005;5:905–916.
4. Hoff SJ, Sundberg P. Breakage and deformation 
characteristics of hypodermic devices under static 
and dynamic loading. Am J Vet Res. 1999;60:292–
298.
Table 2: Incidence of head and neck abscesses at slaughter in pigs vaccinated 
1 and 70 days post weaning using two different injection devices*
Treatment groups
1st vaccination† Needle Needle NFID NFID
Totals (%)
2nd vaccination‡ Needle NFID Needle NFID
Pigs examined  
at slaughter
775 785 790 784 3134
Abscesses right side 3 4 2 5 14 (0.45)a
Abscesses left side 0 4 0 0 4 (0.13)b
Total (%) 3 (0.39)c 8 (1.02)c 2 (0.25)c 5 (0.64)c 18 (0.57)
*     Vaccines were administered either by conventional needle and syringe (Needle) or 
by needle-free injection device (NFID).
†    Mycoflex and Circoflex vaccines were combined (Boehringer Ingelheim Vetmedica 
Inc, St Joseph, Missouri; total 2 mL) and injected on the right side of the neck 1 day 
post weaning in pigs weaned at a mean of 19 days of age. 
‡    ER Bac Plus (Pfizer Inc, Pfizer Animal Health New York, New York, total, 2 mL) was 
injected on the left side of the neck 70 days post weaning.
ab   Proportions differ between sides of the neck (P < .05; McNemar’s test).
c     Proportions do not differ among treatment groups (P > .05; Fisher’s exact test).
